BACKGROUND: The association between prediabetes as currently defined and incident diabetes in populations with widespread obesity, insulin resistance syndrome, and diabetes is not well defined. In this article, diabetes risk factors and incidence rates in American Indians (AI) with prediabetes are examined. METHODS: A total of 1677 AI who were nondiabetic at baseline was examined during a median 7.8-year follow-up as part of the Strong Heart Study (SHS). Risk factors for incident diabetes were measured. Prediabetes was defined according to American Diabetes Association 2003 criteria as having impaired glucose tolerance (IGT) (2-h plasma glucose [2-h PG] >or= 140 mg/dL but < 200 mg/dL) and/or impaired fasting glucose (IFG) (fasting plasma glucose [FPG] >or= 100 mg/dL but < 126 mg/dL). RESULTS: Prediabetes was identified by FPG alone in 87.5%. Diabetes incidence in those with baseline prediabetes was 66.1/1000 person-years, with a hazard ratio (HR) of 2.35 (95% conference interval: 1.84-3.01), compared with participants with normal glucose tolerance (NGT) at baseline. Elevated A(1c), 2-h PG, and fasting insulin (FI); albuminuria; and obesity were significantly associated with conversion from prediabetes to diabetes. Younger age, elevated FI (or body mass index [BMI] in models without FI), and less physical activity were significantly associated with conversion from NGT. CONCLUSIONS: Prediabetes is an independent predictor of conversion to type 2 diabetes in AI, and most can be identified through a fasting glucose measure. Measures of obesity, A(1c), FPG, 2-h PG, FI, albuminuria, and insulin resistance (IR) help predict this conversion. Obesity is a modifiable risk factor. Strategies to reduce obesity should be emphasized in individuals with prediabetes. Copyright (c) 2010 John Wiley & Sons, Ltd.
BACKGROUND: The association between prediabetes as currently defined and incident diabetes in populations with widespread obesity, insulin resistance syndrome, and diabetes is not well defined. In this article, diabetes risk factors and incidence rates in American Indians (AI) with prediabetes are examined. METHODS: A total of 1677 AI who were nondiabetic at baseline was examined during a median 7.8-year follow-up as part of the Strong Heart Study (SHS). Risk factors for incident diabetes were measured. Prediabetes was defined according to American Diabetes Association 2003 criteria as having impaired glucose tolerance (IGT) (2-h plasma glucose [2-h PG] >or= 140 mg/dL but < 200 mg/dL) and/or impaired fasting glucose (IFG) (fasting plasma glucose [FPG] >or= 100 mg/dL but < 126 mg/dL). RESULTS:Prediabetes was identified by FPG alone in 87.5%. Diabetes incidence in those with baseline prediabetes was 66.1/1000 person-years, with a hazard ratio (HR) of 2.35 (95% conference interval: 1.84-3.01), compared with participants with normal glucose tolerance (NGT) at baseline. Elevated A(1c), 2-h PG, and fasting insulin (FI); albuminuria; and obesity were significantly associated with conversion from prediabetes to diabetes. Younger age, elevated FI (or body mass index [BMI] in models without FI), and less physical activity were significantly associated with conversion from NGT. CONCLUSIONS:Prediabetes is an independent predictor of conversion to type 2 diabetes in AI, and most can be identified through a fasting glucose measure. Measures of obesity, A(1c), FPG, 2-h PG, FI, albuminuria, and insulin resistance (IR) help predict this conversion. Obesity is a modifiable risk factor. Strategies to reduce obesity should be emphasized in individuals with prediabetes. Copyright (c) 2010 John Wiley & Sons, Ltd.
Authors: Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Mark S Eberhardt; Katherine M Flegal; Michael M Engelgau; Sharon H Saydah; Desmond E Williams; Linda S Geiss; Edward W Gregg Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112
Authors: M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112
Authors: Dianna J Magliano; Elizabeth L M Barr; Paul Z Zimmet; Adrian J Cameron; David W Dunstan; Stephen Colagiuri; Damien Jolley; Neville Owen; Patrick Phillips; Robyn J Tapp; Tim A Welborn; Jonathan E Shaw Journal: Diabetes Care Date: 2007-11-05 Impact factor: 19.112
Authors: Katherine A Pratte; Ann Johnson; Janette Beals; Ann Bullock; Spero M Manson; Luohua Jiang Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Michelle M Jacob; Kelly L Gonzales; Darren Calhoun; Janette Beals; Clemma Jacobsen Muller; Jack Goldberg; Lonnie Nelson; Thomas K Welty; Barbara V Howard Journal: J Diabetes Complications Date: 2013-09-16 Impact factor: 2.852
Authors: Marilen Federico; Enrique L Portiansky; Leandro Sommese; Francisco J Alvarado; Paula G Blanco; Carolina N Zanuzzi; John Dedman; Marcia Kaetzel; Xander H T Wehrens; Alicia Mattiazzi; Julieta Palomeque Journal: J Physiol Date: 2017-03-02 Impact factor: 5.182
Authors: N Franceschini; K Haack; H H H Göring; V S Voruganti; S Laston; L Almasy; E T Lee; L G Best; R R Fabsitz; K E North; J W Maccluer; J B Meigs; J S Pankow; S A Cole Journal: Diabetologia Date: 2013-07-14 Impact factor: 10.122
Authors: William R Boyer; James R Churilla; Samantha F Ehrlich; Scott E Crouter; Lyndsey M Hornbuckle; Eugene C Fitzhugh Journal: J Diabetes Date: 2017-07-04 Impact factor: 4.006
Authors: Kathryn R Koller; Jesse S Metzger; Stacey E Jolly; Jason G Umans; Scarlett E Hopkins; Cristiane Kaufmann; Amy S Wilson; Sven O E Ebbesson; Terry W Raymer; Melissa A Austin; Barbara V Howard; Bert B Boyer Journal: Diabetes Res Clin Pract Date: 2015-03-11 Impact factor: 5.602
Authors: Sara Nunes; Edna Soares; João Fernandes; Sofia Viana; Eugénia Carvalho; Frederico C Pereira; Flávio Reis Journal: Cardiovasc Diabetol Date: 2013-03-07 Impact factor: 9.951